Unresectable Rectal Neoplasms
Showing 1 - 25 of >10,000
Rectal Tumors Trial in Guangzhou (Irreversible electroporation (IRE), NanoKnife)
Completed
- Rectal Neoplasms
- Irreversible electroporation (IRE)
- NanoKnife
-
Guangzhou, Guangdong, ChinaBiological treatment center in Fuda cancer hospital
Sep 1, 2021
Rectal Cancer, Recurrent Trial in Shanghai (Carbon ion radiation therapy DT: 74Gy/20 fractions)
Not yet recruiting
- Rectal Cancer
- Recurrent
- Carbon ion radiation therapy DT: 74Gy/20 fractions
-
Shanghai, Pudong, ChinaShanghai Proton and Heavy ion center
Apr 7, 2023
Metastatic Colon Adenocarcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Adenocarcinoma Trial in Houston (CXCR1/2
Recruiting
- Metastatic Colon Adenocarcinoma
- +20 more
- CXCR1/2 Inhibitor SX-682
- Nivolumab
-
Houston, TexasM D Anderson Cancer Center
Aug 17, 2022
Rectal Adenocarcinoma, Recurrent Rectal Carcinoma, Stage IV Rectal Cancer AJCC v7 Trial in Scottsdale, Rochester (other,
Completed
- Rectal Adenocarcinoma
- +4 more
- Quality-of-Life Assessment
- +2 more
-
Scottsdale, Arizona
- +1 more
Jan 3, 2023
Palliative Primary Tumor Resection in Minimally Symptomatic
Recruiting
- Colorectal Neoplasms
- +12 more
- surgery of the primary tumour
- chemotherapy
-
Moscow, Russian FederationRyzhikh National Medical Research Center of Coloproctology
Apr 2, 2022
Advanced Colorectal Carcinoma, Metastatic Colon Adenocarcinoma, Metastatic Rectal Adenocarcinoma Trial in United States
Recruiting
- Advanced Colorectal Carcinoma
- +26 more
- Irinotecan
- +2 more
-
Tampa, Florida
- +3 more
Jun 22, 2022
Metastatic or Unresectable Colon or Rectal Cancer forCOLOMATE
Recruiting
- Metastatic Colon Adenocarcinoma
- +19 more
- Genetic Testing
-
Scottsdale, Arizona
- +17 more
Mar 2, 2022
Rectal Tumors Trial in Beijing (SCPRT plus neoadjuvant chemo, long course chemoradiation)
Recruiting
- Rectal Neoplasms
- SCPRT plus neoadjuvant chemotherapy
- long course chemoradiation
-
Beijing, ChinaDepartment of Radiation Oncology, Cancer Institute and Hospital,
Sep 1, 2021
Advanced or Metastatic Solid Tumors, Microsatellite Instability Low, Microsatellite Instability High Trial in United States
Recruiting
- Advanced or Metastatic Solid Tumors
- +11 more
-
Tucson, Arizona
- +11 more
Dec 2, 2022
Metastatic Colon Adenocarcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Adenocarcinoma Trial in Houston
Recruiting
- Metastatic Colon Adenocarcinoma
- +30 more
- Abemaciclib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 24, 2022
Rectal Cancer Trial in Kaohsiung City (drug, procedure, radiation)
Terminated
- Rectal Cancer
- PEP503
- +4 more
-
Kaohsiung City, TaiwanKaohsiung Medical University Hospital
Dec 17, 2021
Colorectal Cancer, Colon Cancer, Rectal Cancer Trial in Newport Beach (hMN14 (labetuzumab))
Completed
- Colorectal Cancer
- +6 more
- hMN14 (labetuzumab)
-
Newport Beach, CaliforniaHoag Cancer Center
Aug 12, 2021
Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +19 more
- A2B694
- xT CDx with HLA-LOH Assay
-
Duarte, California
- +9 more
Sep 22, 2023
Adult Solid Tumor, Bladder Carcinoma, Colon Carcinoma Trial in Duarte (Laboratory Biomarker Analysis, Modified Vaccinia Virus
Active, not recruiting
- Adult Solid Neoplasm
- +16 more
- Laboratory Biomarker Analysis
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Advanced Rectal Cancer, Distal Metastasis Trial in Shanghai (a combination therapy)
Not yet recruiting
- Advanced Rectal Cancer
- Distal Metastasis
- a combination therapy including tislelizumab
-
Shanghai, Shanghai, ChinaXinxiang Li
Nov 12, 2022
Colon Cancer, Rectal Cancer Trial in New York (Floxuridine, Oxaliplatin, CPT-11)
Completed
- Colon Cancer
- Rectal Cancer
- Floxuridine, Oxaliplatin, CPT-11
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jun 29, 2021
Metastatic Colon Adenocarcinoma, Metastatic Rectal Adenocarcinoma, Stage III Colon Cancer AJCC v8 Trial in United States
Recruiting
- Metastatic Colon Adenocarcinoma
- +7 more
- Cetuximab
- +2 more
-
Bloomington, Illinois
- +70 more
Aug 6, 2022
Locally Advanced Rectal Cancer, Total Neoadjuvant Treatment, Anti-PD-1 Trial in Changchun (nCRT ? (CapeOX+Sintilimab)×6 ?
Not yet recruiting
- Locally Advanced Rectal Cancer
- +2 more
- nCRT → (CapeOX+Sintilimab)×6 → Surgery/W&W
-
Changchun, Ji Lin, ChinaFirst Hospital of Jilin University
Aug 11, 2023
FAPI in Rectal Cancer TNT
Not yet recruiting
- Rectal Neoplasms Malignant
- Ga-68 FAPI
-
Taoyuan, TaiwanChang Gung Memorial Hospital
Nov 27, 2023
Gallbladder Tumors Trial in Guangzhou (Irreversible electroporation (IRE), NanoKnife)
Completed
- Gallbladder Neoplasms
- Irreversible electroporation (IRE)
- NanoKnife
-
Guangzhou, Guangdong, ChinaBiological treatment center in Fuda cancer hospital
Sep 1, 2021
Laryngeal Tumors Trial in Guangzhou (Irreversible electroporation (IRE), NanoKnife)
Completed
- Laryngeal Neoplasms
- Irreversible electroporation (IRE)
- NanoKnife
-
Guangzhou, Guangdong, ChinaBiological treatment center in Fuda cancer hospital
Sep 1, 2021
Rectal Tumors Trial (Registry study, no specific intervention)
Not yet recruiting
- Rectal Neoplasms
- Registry study, no specific intervention
- (no location specified)
May 21, 2023
Rectal Tumors Trial in Nanning (Tislelizumab, Capecitabine, Oxaliplatin)
Recruiting
- Rectal Neoplasms
- Tislelizumab
- +4 more
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Aug 27, 2023
MRI T1 Relaxation Time in Rectal Cancer
Recruiting
- Rectal Cancer
- Locally Advanced Rectal Carcinoma
-
Vejle, Jylland, DenmarkVejle Hospital
May 16, 2023
Rectal Cancer Trial in Hamburg (Surgery)
Completed
- Rectal Cancer
- Surgery
-
Hamburg, GermanyUniversity of Hamburg Medical Institutions
Nov 1, 2023